Your browser doesn't support javascript.
Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment.
Liu, Jia; Yang, Xuecheng; Wang, Hua; Li, Ziwei; Deng, Hui; Liu, Jing; Xiong, Shue; He, Junyi; Feng, Xuemei; Guo, Chunxia; Wang, Weixian; Zelinskyy, Gennadiy; Trilling, Mirko; Sutter, Kathrin; Senff, Tina; Menne, Christopher; Timm, Joerg; Zhang, Yanfang; Deng, Fei; Lu, Yinping; Wu, Jun; Lu, Mengji; Yang, Dongliang; Dittmer, Ulf; Wang, Baoju; Zheng, Xin.
  • Liu J; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China jialiu77@hust.edu.cn bjwang73@163.com.
  • Yang X; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Wang H; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Li Z; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Deng H; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Liu J; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Xiong S; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • He J; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Feng X; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Guo C; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wang W; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Zelinskyy G; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Trilling M; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Sutter K; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Senff T; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Menne C; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Timm J; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Zhang Y; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Deng F; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Lu Y; Institute for Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany.
  • Wu J; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Lu M; Institute for Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany.
  • Yang D; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Dittmer U; Institute for Virology, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany.
  • Wang B; Joint International Laboratory of Infection and Immunity, Huazhong University of Science and Technology, Wuhan, China.
  • Zheng X; Institute for Virology, Heinrich-Heine-University, University Hospital, Duesseldorf, Germany.
mBio ; 12(2)2021 04 27.
Article in English | MEDLINE | ID: covidwho-1206004
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affected over 120 million people and killed over 2.7 million individuals by March 2021. While acute and intermediate interactions between SARS-CoV-2 and the immune system have been studied extensively, long-term impacts on the cellular immune system remain to be analyzed. Here, we comprehensively characterized immunological changes in peripheral blood mononuclear cells in 49 COVID-19-convalescent individuals (CI) in comparison to 27 matched SARS-CoV-2-unexposed individuals (UI). Despite recovery from the disease for more than 2 months, CI showed significant decreases in frequencies of invariant NKT and NKT-like cells compared to UI. Concomitant with the decrease in NKT-like cells, an increase in the percentage of annexin V and 7-aminoactinomycin D (7-AAD) double-positive NKT-like cells was detected, suggesting that the reduction in NKT-like cells results from cell death months after recovery. Significant increases in regulatory T cell frequencies and TIM-3 expression on CD4 and CD8 T cells were also observed in CI, while the cytotoxic potential of T cells and NKT-like cells, defined by granzyme B (GzmB) expression, was significantly diminished. However, both CD4 and CD8 T cells of CI showed increased Ki67 expression and were fully able to proliferate and produce effector cytokines upon T cell receptor (TCR) stimulation. Collectively, we provide a comprehensive characterization of immune signatures in patients recovering from SARS-CoV-2 infection, suggesting that the cellular immune system of COVID-19 patients is still under a sustained influence even months after the recovery from disease.IMPORTANCE Wuhan was the very first city hit by SARS-CoV-2. Accordingly, the patients who experienced the longest phase of convalescence following COVID-19 reside here. This enabled us to investigate the "immunological scar" left by SARS-CoV-2 on cellular immunity after recovery from the disease. In this study, we characterized the long-term impact of SARS-CoV-2 infection on the immune system and provide a comprehensive picture of cellular immunity of a convalescent COVID-19 patient cohort with the longest recovery time. We revealed that the cellular immune system of COVID-19 patients is still under a sustained influence even months after the recovery from disease; in particular, a profound NKT cell impairment was found in the convalescent phase of COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Convalescence / Natural Killer T-Cells / COVID-19 / Immunity, Cellular Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Female / Humans / Male / Middle aged Language: English Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Convalescence / Natural Killer T-Cells / COVID-19 / Immunity, Cellular Type of study: Cohort study / Diagnostic study / Experimental Studies / Observational study / Prognostic study Topics: Long Covid Limits: Adult / Female / Humans / Male / Middle aged Language: English Year: 2021 Document Type: Article